EIF2A and prostate cancer: Calreticulin is also necessary for p53 function an important tumor suppressor [69].The eIF2α/ATF4 and ATF6 pathways are downregulated in genetic models of prostate cancer, and their activation by BA is consistent with its reported chemopreventative effect in human populations [86].